Fecal and serum BA and C4 concentrations were high in patients with NAFLD with worsening of fibrosis, suggesting involvement of abnormal BA metabolism in NAFLD with fibrosis progression. This evidence concerns the gene C4A and metabolic dysfunction-associated steatotic liver disease.